ONKORISKTM TEST Options
OnkoRisk’s streamlined test menu focuses on genes with definitive or well-established guideline-based evidence of clinical utility. OnkoRisk panels have been carefully curated by a board certified team of molecular pathologists, clinical molecular geneticists, and genetic counselors.
Testing options available:
OnkoRisk BRCA Panel (2 genes)
Test code: TP68-3 (Non-NYS Only)
BRCA1 |
BRCA2 |
OnkoRisk Hereditary Oncology Management Panel (17 genes)
Test code: TP65-9 (Non-NYS Only)
APC |
ATM |
BMPR1A |
BRCA1 |
BRCA2 |
CDH1 |
CHEK2 |
EPCAM |
MLH1 |
MSH2 |
MSH6 |
MUTYH |
PALB2 |
PMS2 |
PTEN |
STK11 |
TP53 |
OnkoRisk Hereditary Urology Panel† (19 genes)
Test Code: TP66-7 (Non-NYS Only)
ATM |
BARD1 |
BRCA1 |
BRCA2 |
BRIP1 |
CDH1 |
CHEK2 |
EPCAM |
HOXB13 |
MLH1 |
MSH2 |
MSH6 |
PALB2 |
PMS2 |
PTEN |
RAD51C |
RAD51D |
STK11 |
TP53 |
†Panel may determine patient’s risk for prostate cancer.
OnkoRisk Women’s Hereditary Cancer Panel* (19 genes)
Test Code: TP67-5 (Non-NYS Only)
ATM |
BARD1 |
BRCA1 |
BRCA2 |
BRIP1 |
CDH1 |
CHEK2 |
EPCAM |
MLH1 |
MSH2 |
MSH6 |
NF1 |
PALB2 |
PMS2 |
PTEN |
RAD51C |
RAD51D |
STK11 |
TP53 |
*Panel may determine patient’s risk for breast, ovarian, and endometrial cancer.
OnkoRisk Hereditary Oncology Guideline Panel (55 genes)
Test Code: TP70-9 (Non-NYS Only)
APC |
ATM |
AXIN2 |
BAP1 |
BARD1 |
BMPR1A |
BRCA1 |
BRCA2 |
BRIP1 |
CDH1 |
CDK4 |
CDKN1B |
CDKN2A |
CHEK2 |
EPCAM |
FH |
FLCN |
GREM1 |
HOXB13 |
MAX |
MEN1 |
MET |
MLH1 |
MSH2 |
MSH3 |
MSH6 |
MUTYH |
NF1 |
NF2 |
PALB2 |
PMS2 |
POLD1 |
POLE |
PRKAR1A |
PTCH1 |
PTEN |
RAD51B |
RAD51C |
RAD51D |
RB1 |
RET |
SDHA |
SDHAF2 |
SDHB |
SDHC |
SDHD |
SMAD4 |
STK11 |
SUFU |
TMEM127 |
TP53 |
TSC1 |
TSC2 |
VHL |
WT1 |
OnkoRisk Hereditary Oncology Plus Panel (77 genes)
Test Code: TP69-1 (Non-NYS Only)
ALK |
APC |
ATM |
AXIN2 |
BAP1 |
BARD1 |
BLM |
BMPR1A |
BRCA1 |
BRCA2 |
BRIP1 |
CDC73 |
CDH1 |
CDK4 |
CDKN1B |
CDKN2A |
CHEK2 |
CTNNA1 |
DICER1 |
EGFR |
EPCAM |
FANCA |
FANCC |
FANCD2 |
FANCE |
FANCF |
FANCG |
FANCI |
FANCL |
FH |
FLCN |
GREM1 |
HOXB13 |
KIT |
LZTR1 |
MAX |
MEN1 |
MET |
MITF |
MLH1 |
MSH2 |
MSH3 |
MSH6 |
MUTYH |
NBN |
NF1 |
NF2 |
PALB2 |
PDGFRA |
PHOX2B |
PMS2 |
POLD1 |
POLE |
PRKARA1 |
PTCH1 |
PTEN |
RAD51B |
RAD51C |
RAD51D |
RB1 |
RET |
SDHA |
SDHAF2 |
SDHB |
SDHC |
SDHD |
SMAD4 |
SMARCA4 |
SMARCB1 |
STK11 |
SUFU |
TMEM127 |
TP53 |
TSC1 |
TSC2 |
VHL |
WT1 |
Healthcare providers should only order panels if each gene or test in the panel is medically necessary.
OnkoRiskTM is pending NY State approval.